Cargando…

Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases

Background: Increased arterial stiffness (AS), intima-media thickness (IMT), and the presence of atherosclerotic plaques (PP) have been considered as important aspects of vascular aging. It is well documented that the cardiovascular system is an important target organ for growth hormone (GH) and ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Strazhesko, Irina D., Tkacheva, Olga N., Akasheva, Dariga U., Dudinskaya, Ekaterina N., Plokhova, Ekaterina V., Pykhtina, Valentina S., Kruglikova, Anna S., Brailova, Natalia V., Sharashkina, Natalia V., Kashtanova, Daria A., Isaykina, Olesya Y., Pokrovskaya, Mariya S., Vygodin, Vladimir A., Ozerova, Irina N., Skvortsov, Dmitry A., Boytsov, Sergey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770739/
https://www.ncbi.nlm.nih.gov/pubmed/29375617
http://dx.doi.org/10.3389/fgene.2017.00198
_version_ 1783293126887079936
author Strazhesko, Irina D.
Tkacheva, Olga N.
Akasheva, Dariga U.
Dudinskaya, Ekaterina N.
Plokhova, Ekaterina V.
Pykhtina, Valentina S.
Kruglikova, Anna S.
Brailova, Natalia V.
Sharashkina, Natalia V.
Kashtanova, Daria A.
Isaykina, Olesya Y.
Pokrovskaya, Mariya S.
Vygodin, Vladimir A.
Ozerova, Irina N.
Skvortsov, Dmitry A.
Boytsov, Sergey A.
author_facet Strazhesko, Irina D.
Tkacheva, Olga N.
Akasheva, Dariga U.
Dudinskaya, Ekaterina N.
Plokhova, Ekaterina V.
Pykhtina, Valentina S.
Kruglikova, Anna S.
Brailova, Natalia V.
Sharashkina, Natalia V.
Kashtanova, Daria A.
Isaykina, Olesya Y.
Pokrovskaya, Mariya S.
Vygodin, Vladimir A.
Ozerova, Irina N.
Skvortsov, Dmitry A.
Boytsov, Sergey A.
author_sort Strazhesko, Irina D.
collection PubMed
description Background: Increased arterial stiffness (AS), intima-media thickness (IMT), and the presence of atherosclerotic plaques (PP) have been considered as important aspects of vascular aging. It is well documented that the cardiovascular system is an important target organ for growth hormone (GH) and insulin-like growth factor (IGF)-1 in humans, and GH /IGF-1 deficiency significantly increases the risk for cardiovascular diseases (CVD). The telomere length of peripheral blood leukocytes (LTL) is a biomarker of cellular senescence and that has been proposed as an independent predictor of (CVD). The aim of this study is to determine the role of GH/IGF-1, LTL and their interaction cardiovascular risk factors (CVRF) in the vascular aging. Methods: The study group included 303 ambulatory participants free of known CVD (104 males and 199 females) with a mean age of 51.8 ± 13.3 years. All subjects had one or more CVRF [age, smoking, arterial hypertension, obesity, dyslipidemia, fasting hyperglycemia, insulin resistance—HOMA (homeostatic model assessment) >2.5, or high glycated hemoglobin]. The study sample was divided into the two groups according to age as “younger” (m ≤ 45 years, f ≤ 55 years) and “older” (m > 45 years, f > 55 years). IMT and PP were determined by ultrasonography, AS was determined by measuring the carotid-femoral pulse wave velocity (c-f PWV) using the SphygmoCor system (AtCor Medical). LTL was determined by PCR. Serum IGF-1 and GH concentrations we measured by immunochemiluminescence analysis. Results: Multiple linear regression analysis with adjustment for CVRF indicated that HOMA, GH, IGF-1, and LTL had an independent relationship with all the arterial wall parameters investigated in the younger group. In the model with c-f PWV as a dependent variable, p < 0.001 for HOMA, p = 0.03 for GH, and p = 0.004 for LTL. In the model with IMT as a dependent variable, p = 0.0001 for HOMA, p = 0.044 for GH, and p = 0.004 for IGF-1. In the model with the number of plaques as a dependent variable, p = 0.0001 for HOMA, and p = 0.045 for IGF-1. In the older group, there were no independent significant associations between GH/IGF-1, LTL, HOMA, and arterial wall characteristics. Conclusions: GH/IGF-1, IR, HOMA, and LTL were the important parameters of arterial aging in younger healthy participants.
format Online
Article
Text
id pubmed-5770739
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57707392018-01-26 Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases Strazhesko, Irina D. Tkacheva, Olga N. Akasheva, Dariga U. Dudinskaya, Ekaterina N. Plokhova, Ekaterina V. Pykhtina, Valentina S. Kruglikova, Anna S. Brailova, Natalia V. Sharashkina, Natalia V. Kashtanova, Daria A. Isaykina, Olesya Y. Pokrovskaya, Mariya S. Vygodin, Vladimir A. Ozerova, Irina N. Skvortsov, Dmitry A. Boytsov, Sergey A. Front Genet Genetics Background: Increased arterial stiffness (AS), intima-media thickness (IMT), and the presence of atherosclerotic plaques (PP) have been considered as important aspects of vascular aging. It is well documented that the cardiovascular system is an important target organ for growth hormone (GH) and insulin-like growth factor (IGF)-1 in humans, and GH /IGF-1 deficiency significantly increases the risk for cardiovascular diseases (CVD). The telomere length of peripheral blood leukocytes (LTL) is a biomarker of cellular senescence and that has been proposed as an independent predictor of (CVD). The aim of this study is to determine the role of GH/IGF-1, LTL and their interaction cardiovascular risk factors (CVRF) in the vascular aging. Methods: The study group included 303 ambulatory participants free of known CVD (104 males and 199 females) with a mean age of 51.8 ± 13.3 years. All subjects had one or more CVRF [age, smoking, arterial hypertension, obesity, dyslipidemia, fasting hyperglycemia, insulin resistance—HOMA (homeostatic model assessment) >2.5, or high glycated hemoglobin]. The study sample was divided into the two groups according to age as “younger” (m ≤ 45 years, f ≤ 55 years) and “older” (m > 45 years, f > 55 years). IMT and PP were determined by ultrasonography, AS was determined by measuring the carotid-femoral pulse wave velocity (c-f PWV) using the SphygmoCor system (AtCor Medical). LTL was determined by PCR. Serum IGF-1 and GH concentrations we measured by immunochemiluminescence analysis. Results: Multiple linear regression analysis with adjustment for CVRF indicated that HOMA, GH, IGF-1, and LTL had an independent relationship with all the arterial wall parameters investigated in the younger group. In the model with c-f PWV as a dependent variable, p < 0.001 for HOMA, p = 0.03 for GH, and p = 0.004 for LTL. In the model with IMT as a dependent variable, p = 0.0001 for HOMA, p = 0.044 for GH, and p = 0.004 for IGF-1. In the model with the number of plaques as a dependent variable, p = 0.0001 for HOMA, and p = 0.045 for IGF-1. In the older group, there were no independent significant associations between GH/IGF-1, LTL, HOMA, and arterial wall characteristics. Conclusions: GH/IGF-1, IR, HOMA, and LTL were the important parameters of arterial aging in younger healthy participants. Frontiers Media S.A. 2017-12-15 /pmc/articles/PMC5770739/ /pubmed/29375617 http://dx.doi.org/10.3389/fgene.2017.00198 Text en Copyright © 2017 Strazhesko, Tkacheva, Akasheva, Dudinskaya, Plokhova, Pykhtina, Kruglikova, Brailova, Sharashkina, Kashtanova, Isaykina, Pokrovskaya, Vygodin, Ozerova, Skvortsov and Boytsov. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Strazhesko, Irina D.
Tkacheva, Olga N.
Akasheva, Dariga U.
Dudinskaya, Ekaterina N.
Plokhova, Ekaterina V.
Pykhtina, Valentina S.
Kruglikova, Anna S.
Brailova, Natalia V.
Sharashkina, Natalia V.
Kashtanova, Daria A.
Isaykina, Olesya Y.
Pokrovskaya, Mariya S.
Vygodin, Vladimir A.
Ozerova, Irina N.
Skvortsov, Dmitry A.
Boytsov, Sergey A.
Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases
title Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases
title_full Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases
title_fullStr Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases
title_full_unstemmed Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases
title_short Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases
title_sort growth hormone, insulin-like growth factor-1, insulin resistance, and leukocyte telomere length as determinants of arterial aging in subjects free of cardiovascular diseases
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770739/
https://www.ncbi.nlm.nih.gov/pubmed/29375617
http://dx.doi.org/10.3389/fgene.2017.00198
work_keys_str_mv AT strazheskoirinad growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT tkachevaolgan growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT akashevadarigau growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT dudinskayaekaterinan growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT plokhovaekaterinav growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT pykhtinavalentinas growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT kruglikovaannas growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT brailovanataliav growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT sharashkinanataliav growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT kashtanovadariaa growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT isaykinaolesyay growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT pokrovskayamariyas growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT vygodinvladimira growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT ozerovairinan growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT skvortsovdmitrya growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases
AT boytsovsergeya growthhormoneinsulinlikegrowthfactor1insulinresistanceandleukocytetelomerelengthasdeterminantsofarterialaginginsubjectsfreeofcardiovasculardiseases